Skip to main content
NCBI home page
CMAJ : Canadian Medical Association Journal logoLink to CMAJ : Canadian Medical Association Journal
. 1993 Sep 15;149(6):821–826.

Report of the Canadian Hypertension Society Consensus Conference: 5. Hypertension and diabetes.

K G Dawson 1, J K McKenzie 1, S A Ross 1, J L Chiasson 1, P Hamet 1
PMCID: PMC1485364  PMID: 8374845

Full text

PDF
821

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baba T., Murabayashi S., Takebe K. Comparison of the renal effects of angiotensin converting enzyme inhibitor and calcium antagonist in hypertensive type 2 (non-insulin-dependent) diabetic patients with microalbuminuria: a randomised controlled trial. Diabetologia. 1989 Jan;32(1):40–44. doi: 10.1007/BF00265402. [DOI] [PubMed] [Google Scholar]
  2. Bakris G. L. Effects of diltiazem or lisinopril on massive proteinuria associated with diabetes mellitus. Ann Intern Med. 1990 May 1;112(9):707–708. doi: 10.7326/0003-4819-112-9-707. [DOI] [PubMed] [Google Scholar]
  3. Bangstad H. J., Try K., Dahl-Jørgensen K., Hanssen K. F. New semiquantitative dipstick test for microalbuminuria. Diabetes Care. 1991 Nov;14(11):1094–1097. doi: 10.2337/diacare.14.11.1094. [DOI] [PubMed] [Google Scholar]
  4. Bending J. J., Viberti G. C., Bilous R. W., Keen H. Eight-month correction of hyperglycemia in insulin-dependent diabetes mellitus is associated with a significant and sustained reduction of urinary albumin excretion rates in patients with microalbuminuria. Diabetes. 1985 Aug;34 (Suppl 3):69–73. doi: 10.2337/diab.34.3.s69. [DOI] [PubMed] [Google Scholar]
  5. Berne C., Pollare T., Lithell H. Effects of antihypertensive treatment on insulin sensitivity with special reference to ACE inhibitors. Diabetes Care. 1991 Nov;14 (Suppl 4):39–47. doi: 10.2337/diacare.14.4.39. [DOI] [PubMed] [Google Scholar]
  6. Chockalingam A., Abbott D., Bass M., Battista R., Cameron R., de Champlain J., Evans C. E., Laidlaw J., Lee B. L., Leiter L. Recommendations of the Canadian Consensus Conference on Non-Pharmacological Approaches to the Management of High Blood Pressure, Mar. 21-23, 1989, Halifax, Nova Scotia. CMAJ. 1990 Jun 15;142(12):1397–1409. [PMC free article] [PubMed] [Google Scholar]
  7. Christlieb A. R. Treatment selection considerations for the hypertensive diabetic patient. Arch Intern Med. 1990 Jun;150(6):1167–1174. [PubMed] [Google Scholar]
  8. Corrall R. J., Frier B. M., Davidson N. M., French E. B. Hormonal and substrate responses during recovery from hypoglycaemia in man during beta 1-selective and non-selective beta-adrenergic blockade. Eur J Clin Invest. 1981 Aug;11(4):279–283. doi: 10.1111/j.1365-2362.1981.tb02117.x. [DOI] [PubMed] [Google Scholar]
  9. Dahl-Jørgensen K., Hanssen K. F., Kierulf P., Bjøro T., Sandvik L., Aagenaes O. Reduction of urinary albumin excretion after 4 years of continuous subcutaneous insulin infusion in insulin-dependent diabetes mellitus. The Oslo Study. Acta Endocrinol (Copenh) 1988 Jan;117(1):19–25. doi: 10.1530/acta.0.1170019. [DOI] [PubMed] [Google Scholar]
  10. Damsgaard E. M., Frøland A., Jørgensen O. D., Mogensen C. E. Eight to nine year mortality in known non-insulin dependent diabetics and controls. Kidney Int. 1992 Apr;41(4):731–735. doi: 10.1038/ki.1992.114. [DOI] [PubMed] [Google Scholar]
  11. DeFronzo R. A. The effect of insulin on renal sodium metabolism. A review with clinical implications. Diabetologia. 1981 Sep;21(3):165–171. doi: 10.1007/BF00252649. [DOI] [PubMed] [Google Scholar]
  12. Demarie B. K., Bakris G. L. Effects of different calcium antagonists on proteinuria associated with diabetes mellitus. Ann Intern Med. 1990 Dec 15;113(12):987–988. doi: 10.7326/0003-4819-113-12-987. [DOI] [PubMed] [Google Scholar]
  13. Dornhorst A., Powell S. H., Pensky J. Aggravation by propranolol of hyperglycaemic effect of hydrochlorothiazide in type II diabetics without alteration of insulin secretion. Lancet. 1985 Jan 19;1(8421):123–126. doi: 10.1016/s0140-6736(85)91900-2. [DOI] [PubMed] [Google Scholar]
  14. Eriksson K. F., Lindgärde F. Prevention of type 2 (non-insulin-dependent) diabetes mellitus by diet and physical exercise. The 6-year Malmö feasibility study. Diabetologia. 1991 Dec;34(12):891–898. doi: 10.1007/BF00400196. [DOI] [PubMed] [Google Scholar]
  15. Feldt-Rasmussen B., Mathiesen E. R., Deckert T. Effect of two years of strict metabolic control on progression of incipient nephropathy in insulin-dependent diabetes. Lancet. 1986 Dec 6;2(8519):1300–1304. doi: 10.1016/s0140-6736(86)91433-9. [DOI] [PubMed] [Google Scholar]
  16. Ferrier C., Ferrari P., Weidmann P., Keller U., Beretta-Piccoli C., Riesen W. F. Antihypertensive therapy with Ca2+. Antagonist verapamil and/or ACE inhibitor enalapril in NIDDM patients. Diabetes Care. 1991 Oct;14(10):911–914. doi: 10.2337/diacare.14.10.911. [DOI] [PubMed] [Google Scholar]
  17. Fuller J. H., Shipley M. J., Rose G., Jarrett R. J., Keen H. Coronary-heart-disease risk and impaired glucose tolerance. The Whitehall study. Lancet. 1980 Jun 28;1(8183):1373–1376. doi: 10.1016/s0140-6736(80)92651-3. [DOI] [PubMed] [Google Scholar]
  18. Fuller J. H., Shipley M. J., Rose G., Jarrett R. J., Keen H. Mortality from coronary heart disease and stroke in relation to degree of glycaemia: the Whitehall study. Br Med J (Clin Res Ed) 1983 Sep 24;287(6396):867–870. doi: 10.1136/bmj.287.6396.867. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Fuller J. H., Stevens L. K. Epidemiology of hypertension in diabetic patients and implications for treatment. Diabetes Care. 1991 Nov;14 (Suppl 4):8–12. doi: 10.2337/diacare.14.4.8. [DOI] [PubMed] [Google Scholar]
  20. Gambardella S., Frontoni S., Grazia Felici M., Spallone V., Gargiulo P., Morano S., Menzinger G. Efficacy of antihypertensive treatment with indapamide in patients with noninsulin-dependent diabetes and persistent microalbuminuria. Am J Cardiol. 1990 May 2;65(17):46H–50H. doi: 10.1016/0002-9149(90)90342-x. [DOI] [PubMed] [Google Scholar]
  21. Gambardella S., Frontoni S., Lala A., Felici M. G., Spallone V., Scoppola A., Jacoangeli F., Menzinger G. Regression of microalbuminuria in type II diabetic, hypertensive patients after long-term indapamide treatment. Am Heart J. 1991 Oct;122(4 Pt 2):1232–1238. doi: 10.1016/0002-8703(91)90946-f. [DOI] [PubMed] [Google Scholar]
  22. Golay A., Chen Y. D., Reaven G. M. Effect of differences in glucose tolerance on insulin's ability to regulate carbohydrate and free fatty acid metabolism in obese individuals. J Clin Endocrinol Metab. 1986 Jun;62(6):1081–1088. doi: 10.1210/jcem-62-6-1081. [DOI] [PubMed] [Google Scholar]
  23. Gurwitz J. H., Bohn R. L., Glynn R. J., Monane M., Mogun H., Avorn J. Antihypertensive drug therapy and the initiation of treatment for diabetes mellitus. Ann Intern Med. 1993 Feb 15;118(4):273–278. doi: 10.7326/0003-4819-118-4-199302150-00005. [DOI] [PubMed] [Google Scholar]
  24. Hadrava V., Kruppa U., Russo R. C., Lacourcière Y., Tremblay J., Hamet P. Vascular smooth muscle cell proliferation and its therapeutic modulation in hypertension. Am Heart J. 1991 Oct;122(4 Pt 2):1198–1203. doi: 10.1016/0002-8703(91)90939-f. [DOI] [PubMed] [Google Scholar]
  25. Hamet P., Kalant N., Ross S. A., Wilson T. W., Leenen F. H., Haynes R. B. Recommendations from the Canadian Hypertension Society Consensus Conference on Hypertension and Diabetes. CMAJ. 1988 Dec 1;139(11):1059–1062. [PMC free article] [PubMed] [Google Scholar]
  26. Haynes R. B., Lacourcière Y., Rabkin S. W., Leenen F. H., Logan A. G., Wright N., Evans C. E. Report of the Canadian Hypertension Society Consensus Conference: 2. Diagnosis of hypertension in adults. CMAJ. 1993 Aug 15;149(4):409–418. [PMC free article] [PubMed] [Google Scholar]
  27. Holm G., Johansson S., Vedin A., Wilhelmsson C., Smith U. The effect of beta-blockade on glucose tolerance and insulin release in adult diabetes. Acta Med Scand. 1980;208(3):187–191. doi: 10.1111/j.0954-6820.1980.tb01175.x. [DOI] [PubMed] [Google Scholar]
  28. Jensen J. S., Mathiesen E. R., Nørgaard K., Hommel E., Borch-Johnsen K., Funder J., Brahm J., Parving H. H., Deckert T. Increased blood pressure and erythrocyte sodium/lithium countertransport activity are not inherited in diabetic nephropathy. Diabetologia. 1990 Oct;33(10):619–624. doi: 10.1007/BF00400206. [DOI] [PubMed] [Google Scholar]
  29. Jerums G., Allen T. J., Tsalamandris C., Cooper M. E. Angiotensin converting enzyme inhibition and calcium channel blockade in incipient diabetic nephropathy. The Melbourne Diabetic Nephropathy Study Group. Kidney Int. 1992 Apr;41(4):904–911. doi: 10.1038/ki.1992.138. [DOI] [PubMed] [Google Scholar]
  30. Johnston C. I., Cooper M. E., Nicholls G. M. Meeting report of the International Society of Hypertension Conference on Hypertension and Diabetes. J Hypertens. 1992 Apr;10(4):393–397. doi: 10.1097/00004872-199204000-00012. [DOI] [PubMed] [Google Scholar]
  31. Kannel W. B., McGee D. L. Diabetes and cardiovascular risk factors: the Framingham study. Circulation. 1979 Jan;59(1):8–13. doi: 10.1161/01.cir.59.1.8. [DOI] [PubMed] [Google Scholar]
  32. Kasiske B. L., Kalil R. S., Ma J. Z., Liao M., Keane W. F. Effect of antihypertensive therapy on the kidney in patients with diabetes: a meta-regression analysis. Ann Intern Med. 1993 Jan 15;118(2):129–138. doi: 10.7326/0003-4819-118-2-199301150-00009. [DOI] [PubMed] [Google Scholar]
  33. Klein R., Klein B. E., Moss S. E., Davis M. D., DeMets D. L. Is blood pressure a predictor of the incidence or progression of diabetic retinopathy? Arch Intern Med. 1989 Nov;149(11):2427–2432. [PubMed] [Google Scholar]
  34. Klein R., Moss S. E., Klein B. E., DeMets D. L. Relation of ocular and systemic factors to survival in diabetes. Arch Intern Med. 1989 Feb;149(2):266–272. [PubMed] [Google Scholar]
  35. Krolewski A. S., Canessa M., Warram J. H., Laffel L. M., Christlieb A. R., Knowler W. C., Rand L. I. Predisposition to hypertension and susceptibility to renal disease in insulin-dependent diabetes mellitus. N Engl J Med. 1988 Jan 21;318(3):140–145. doi: 10.1056/NEJM198801213180303. [DOI] [PubMed] [Google Scholar]
  36. Laakso M., Sarlund H., Mykkänen L. Essential hypertension and insulin resistance in non-insulin-dependent diabetes. Eur J Clin Invest. 1989 Dec;19(6):518–526. doi: 10.1111/j.1365-2362.1989.tb00269.x. [DOI] [PubMed] [Google Scholar]
  37. Lacourcière Y., Nadeau A., Poirier L., Tancrède G. Comparative effects of converting enzyme inhibition and conventional therapy in hypertensive non-insulin dependent diabetics with normal renal function. Clin Invest Med. 1991 Dec;14(6):652–660. [PubMed] [Google Scholar]
  38. Leren P., Foss P. O., Helgeland A., Hjermann I., Holme I., Lund-Larsen P. G. Effect of propranolol and prazosin on blood lipids. The Oslo Study. Lancet. 1980 Jul 5;2(8184):4–6. doi: 10.1016/s0140-6736(80)92888-3. [DOI] [PubMed] [Google Scholar]
  39. Levy P. Effects of prazosin on blood pressure and diabetic control in patients with type II diabetes mellitus and mild essential hypertension. Am J Med. 1989 Jan 23;86(1B):59–62. doi: 10.1016/0002-9343(89)90132-0. [DOI] [PubMed] [Google Scholar]
  40. Lipson L. G. Special problems in treatment of hypertension in the patient with diabetes mellitus. Arch Intern Med. 1984 Sep;144(9):1829–1831. [PubMed] [Google Scholar]
  41. Manicardi V., Camellini L., Bellodi G., Coscelli C., Ferrannini E. Evidence for an association of high blood pressure and hyperinsulinemia in obese man. J Clin Endocrinol Metab. 1986 Jun;62(6):1302–1304. doi: 10.1210/jcem-62-6-1302. [DOI] [PubMed] [Google Scholar]
  42. Marre M., Leblanc H., Suarez L., Guyenne T. T., Ménard J., Passa P. Converting enzyme inhibition and kidney function in normotensive diabetic patients with persistent microalbuminuria. Br Med J (Clin Res Ed) 1987 Jun 6;294(6585):1448–1452. doi: 10.1136/bmj.294.6585.1448. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Mathiesen E. R., Borch-Johnsen K., Jensen D. V., Deckert T. Improved survival in patients with diabetic nephropathy. Diabetologia. 1989 Dec;32(12):884–886. doi: 10.1007/BF00297455. [DOI] [PubMed] [Google Scholar]
  44. Mathiesen E. R., Hommel E., Giese J., Parving H. H. Efficacy of captopril in postponing nephropathy in normotensive insulin dependent diabetic patients with microalbuminuria. BMJ. 1991 Jul 13;303(6794):81–87. doi: 10.1136/bmj.303.6794.81. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Messent J. W., Elliott T. G., Hill R. D., Jarrett R. J., Keen H., Viberti G. C. Prognostic significance of microalbuminuria in insulin-dependent diabetes mellitus: a twenty-three year follow-up study. Kidney Int. 1992 Apr;41(4):836–839. doi: 10.1038/ki.1992.128. [DOI] [PubMed] [Google Scholar]
  46. Mimran A., Insua A., Ribstein J., Bringer J., Monnier L. Comparative effect of captopril and nifedipine in normotensive patients with incipient diabetic nephropathy. Diabetes Care. 1988 Nov-Dec;11(10):850–853. doi: 10.2337/diacare.11.10.850. [DOI] [PubMed] [Google Scholar]
  47. Modan M., Halkin H., Almog S., Lusky A., Eshkol A., Shefi M., Shitrit A., Fuchs Z. Hyperinsulinemia. A link between hypertension obesity and glucose intolerance. J Clin Invest. 1985 Mar;75(3):809–817. doi: 10.1172/JCI111776. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Mogensen C. E., Hansen K. W., Osterby R., Damsgaard E. M. Blood pressure elevation versus abnormal albuminuria in the genesis and prediction of renal disease in diabetes. Diabetes Care. 1992 Sep;15(9):1192–1204. doi: 10.2337/diacare.15.9.1192. [DOI] [PubMed] [Google Scholar]
  49. Mogensen C. E. Prediction of clinical diabetic nephropathy in IDDM patients. Alternatives to microalbuminuria? Diabetes. 1990 Jul;39(7):761–767. doi: 10.2337/diab.39.7.761. [DOI] [PubMed] [Google Scholar]
  50. Morales P. A., Mitchell B. D., Valdez R. A., Hazuda H. P., Stern M. P., Haffner S. M. Incidence of NIDDM and impaired glucose tolerance in hypertensive subjects. The San Antonio Heart Study. Diabetes. 1993 Jan;42(1):154–161. doi: 10.2337/diab.42.1.154. [DOI] [PubMed] [Google Scholar]
  51. Morrish N. J., Stevens L. K., Head J., Fuller J. H., Jarrett R. J., Keen H. A prospective study of mortality among middle-aged diabetic patients (the London Cohort of the WHO Multinational Study of Vascular Disease in Diabetics) II: Associated risk factors. Diabetologia. 1990 Sep;33(9):542–548. doi: 10.1007/BF00404142. [DOI] [PubMed] [Google Scholar]
  52. Nelson R. G., Knowler W. C., Pettitt D. J., Saad M. F., Charles M. A., Bennett P. H. Assessment of risk of overt nephropathy in diabetic patients from albumin excretion in untimed urine specimens. Arch Intern Med. 1991 Sep;151(9):1761–1765. [PubMed] [Google Scholar]
  53. Nørgaard K., Mathiesen E. R., Hommel E., Jensen J. S., Parving H. H. Lack of familial predisposition to cardiovascular disease in type 1 (insulin-dependent) diabetic patients with nephropathy. Diabetologia. 1991 May;34(5):370–372. doi: 10.1007/BF00405012. [DOI] [PubMed] [Google Scholar]
  54. Paolisso G., Marrazzo G., De Riu S., Sgambato S., Varricchio M., D'Onofrio F. Insulin resistance as cause of increased blood pressure in the elderly: effects on intracellular ion contents. Arch Gerontol Geriatr. 1990 Jul-Aug;11(1):23–32. doi: 10.1016/0167-4943(90)90053-9. [DOI] [PubMed] [Google Scholar]
  55. Parving H. H., Hommel E., Damkjaer Nielsen M., Giese J. Effect of captopril on blood pressure and kidney function in normotensive insulin dependent diabetics with nephropathy. BMJ. 1989 Aug 26;299(6698):533–536. doi: 10.1136/bmj.299.6698.533. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Parving H. H., Hommel E., Mathiesen E., Skøtt P., Edsberg B., Bahnsen M., Lauritzen M., Hougaard P., Lauritzen E. Prevalence of microalbuminuria, arterial hypertension, retinopathy and neuropathy in patients with insulin dependent diabetes. Br Med J (Clin Res Ed) 1988 Jan 16;296(6616):156–160. doi: 10.1136/bmj.296.6616.156. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Parving H. H., Hommel E. Prognosis in diabetic nephropathy. BMJ. 1989 Jul 22;299(6693):230–233. doi: 10.1136/bmj.299.6693.230. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Parving H. H., Hommel E., Smidt U. M. Protection of kidney function and decrease in albuminuria by captopril in insulin dependent diabetics with nephropathy. BMJ. 1988 Oct 29;297(6656):1086–1091. doi: 10.1136/bmj.297.6656.1086. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Parving H. H., Hommel E., Smidt U. M. Protection of kidney function and decrease in albuminuria by captopril in insulin dependent diabetics with nephropathy. BMJ. 1988 Oct 29;297(6656):1086–1091. doi: 10.1136/bmj.297.6656.1086. [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Parving H. H. Impact of blood pressure and antihypertensive treatment on incipient and overt nephropathy, retinopathy, and endothelial permeability in diabetes mellitus. Diabetes Care. 1991 Mar;14(3):260–269. doi: 10.2337/diacare.14.3.260. [DOI] [PubMed] [Google Scholar]
  61. Pollare T., Lithell H., Berne C. A comparison of the effects of hydrochlorothiazide and captopril on glucose and lipid metabolism in patients with hypertension. N Engl J Med. 1989 Sep 28;321(13):868–873. doi: 10.1056/NEJM198909283211305. [DOI] [PubMed] [Google Scholar]
  62. Ravid M., Savin H., Jutrin I., Bental T., Katz B., Lishner M. Long-term stabilizing effect of angiotensin-converting enzyme inhibition on plasma creatinine and on proteinuria in normotensive type II diabetic patients. Ann Intern Med. 1993 Apr 15;118(8):577–581. doi: 10.7326/0003-4819-118-8-199304150-00001. [DOI] [PubMed] [Google Scholar]
  63. Reaven G. M. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes. 1988 Dec;37(12):1595–1607. doi: 10.2337/diab.37.12.1595. [DOI] [PubMed] [Google Scholar]
  64. Rimmer J. M., Horn J. F., Gennari F. J. Hyperkalemia as a complication of drug therapy. Arch Intern Med. 1987 May;147(5):867–869. [PubMed] [Google Scholar]
  65. Rowe J. W., Young J. B., Minaker K. L., Stevens A. L., Pallotta J., Landsberg L. Effect of insulin and glucose infusions on sympathetic nervous system activity in normal man. Diabetes. 1981 Mar;30(3):219–225. doi: 10.2337/diab.30.3.219. [DOI] [PubMed] [Google Scholar]
  66. Schmitz A., Vaeth M. Microalbuminuria: a major risk factor in non-insulin-dependent diabetes. A 10-year follow-up study of 503 patients. Diabet Med. 1988 Mar;5(2):126–134. doi: 10.1111/j.1464-5491.1988.tb00958.x. [DOI] [PubMed] [Google Scholar]
  67. Seaquist E. R., Goetz F. C., Rich S., Barbosa J. Familial clustering of diabetic kidney disease. Evidence for genetic susceptibility to diabetic nephropathy. N Engl J Med. 1989 May 4;320(18):1161–1165. doi: 10.1056/NEJM198905043201801. [DOI] [PubMed] [Google Scholar]
  68. Slataper R., Vicknair N., Sadler R., Bakris G. L. Comparative effects of different antihypertensive treatments on progression of diabetic renal disease. Arch Intern Med. 1993 Apr 26;153(8):973–980. [PubMed] [Google Scholar]
  69. Stein P. P., Black H. R. Drug treatment of hypertension in patients with diabetes mellitus. Diabetes Care. 1991 Jun;14(6):425–448. doi: 10.2337/diacare.14.6.425. [DOI] [PubMed] [Google Scholar]
  70. Swislocki A. L., Hoffman B. B., Sheu W. H., Chen Y. D., Reaven G. M. Effect of prazosin treatment on carbohydrate and lipoprotein metabolism in patients with hypertension. Am J Med. 1989 Jan 23;86(1B):14–18. doi: 10.1016/0002-9343(89)90122-8. [DOI] [PubMed] [Google Scholar]
  71. Townsend R. R., Holland O. B. Combination of converting enzyme inhibitor with diuretic for the treatment of hypertension. Arch Intern Med. 1990 Jun;150(6):1175–1183. [PubMed] [Google Scholar]
  72. Tsutsu N., Nunoi K., Yokomizo Y., Kikuchi M., Fujishima M. Relationship between glycemic control and orthostatic hypotension in type 2 diabetes mellitus--a survey by the Fukuoka Diabetes Clinic Group. Diabetes Res Clin Pract. 1990 Jan;8(2):115–123. doi: 10.1016/0168-8227(90)90021-k. [DOI] [PubMed] [Google Scholar]
  73. Walker J. D., Tariq T., Viberti G. Sodium-lithium countertransport activity in red cells of patients with insulin dependent diabetes and nephropathy and their parents. BMJ. 1990 Sep 29;301(6753):635–638. doi: 10.1136/bmj.301.6753.635. [DOI] [PMC free article] [PubMed] [Google Scholar]
  74. Warram J. H., Laffel L. M., Valsania P., Christlieb A. R., Krolewski A. S. Excess mortality associated with diuretic therapy in diabetes mellitus. Arch Intern Med. 1991 Jul;151(7):1350–1356. [PubMed] [Google Scholar]
  75. Wright A. D., Barber S. G., Kendall M. J., Poole P. H. Beta-adrenoceptor-blocking drugs and blood sugar control in diabetes mellitus. Br Med J. 1979 Jan 20;1(6157):159–161. doi: 10.1136/bmj.1.6157.159. [DOI] [PMC free article] [PubMed] [Google Scholar]
  76. Yudkin J. S. Factors influencing threshold and choice of treatment for hypertension in NIDDM. Cardiovascular factors. Diabetes Care. 1991 Nov;14 (Suppl 4):27–32. doi: 10.2337/diacare.14.4.27. [DOI] [PubMed] [Google Scholar]
  77. Zanella M. T., Santiago R. C., de Sá J. R., Salgado B. J., de Faria S. F., Peres R. B., Kohlmann Júnior O., Ribeiro A. B. Hypertension and diabetes. Clinical problems. Drugs. 1988;35 (Suppl 6):135–141. doi: 10.2165/00003495-198800356-00018. [DOI] [PubMed] [Google Scholar]
  78. van Hoeven K. H., Factor S. M. A comparison of the pathological spectrum of hypertensive, diabetic, and hypertensive-diabetic heart disease. Circulation. 1990 Sep;82(3):848–855. doi: 10.1161/01.cir.82.3.848. [DOI] [PubMed] [Google Scholar]

Articles from CMAJ: Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES